Skip to content

Blood Recirculation and vvECMO

Measurment of Blood Recirculation and Adjustment of vvECMO Blood Flow During Veno-venous Extracoporeal Membrane Oxygenation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03200314
Enrollment
21
Registered
2017-06-27
Start date
2017-08-13
Completion date
2018-08-09
Last updated
2020-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Extracorporeal Membrane Oxygenation

Brief summary

A prospective, observational study will be performed measuring recirculation of blood through a veno-venous Extracoporeal Membrane Oxygenation (vvECMO) in patients with acute respiratory distress syndrome (ARDS) on vvECMO. ECMO blood flow will be adjusted with respect to recirculation.

Interventions

OTHERMeasurment of blood recirculation

Ultrasound based measurments of blood recirculating through the vvECMO circuit.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients aged 18 years or older * ARDS * veno-venous ECMO

Exclusion criteria

* age \< 18 years * hemodynamic instability during measurement of recirculation * pregnancy * inability to obtain patient's consent or consent of legal guardian

Design outcomes

Primary

MeasureTime frameDescription
Recirculation of vvECMO blood flowOnce within first week after ICU admission during 4 hoursAmount of ECMO blood flow recirculating through the vvECMO circuit

Secondary

MeasureTime frameDescription
Reduction of vvECMO blood flowOnce within first week after ICU admission during 4 hoursReduction of vvECMO blood flow if a significant recirculation can be measured
Arterial blood oxygen content after reduction of vvECMO blood flowOnce within first week after ICU admission during 4 hoursChange in arterial blood oygen content after reduction of vvECMO blood flow

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026